This guidebook can be used by primary care clinics and other partners to assist with strengthening their setting’s TB prevention activities. The guidebook was developed by staff from the TB Free California initiative, a project of the California Department of Public Health.
This material was developed for clinicians to use with patients that are prescribed the four months daily rifampin (4R) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist...
This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There...
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. English is on one side and Russian is on the other.
The patient education brochure was developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events.
This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There...
This document provides specific guidance for screening and post- screening management of all people who have been identified through public health investigations as having been exposed to multidrug resistant tuberculosis (MDR TB). Recommendations for symptomatic contacts, children less than 5 years...
The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the...
To commemorate June 5th and our 40 Years of Progress, federal agencies are holding a special series of Live with Leadership sessions hosted by Harold Phillips, Chief Operating Officer for Ending the HIV Epidemic in the U.S., to reflect upon and honor the anniversary.
“Community Dialogue: June 5th...
This Live with Leadership features Dr. Tim Harrison, Deputy Director for Strategic Initiatives & Senior Policy Advisor Office of Infectious Disease and HIV/AIDS Policy, HHS joined by Dr. Laura Cheever, Associate Administrator, HIV/AIDS Bureau, Health Resources and Services Administration, and Dr...
